XRAY vs EXPD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

XRAY

52.3
AI Score
VS
EXPD Wins

EXPD

58.5
AI Score

Investment Advisor Scores

XRAY

52score
Recommendation
HOLD

EXPD

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY EXPD Winner
Forward P/E 10.0705 26.8817 XRAY
PEG Ratio 0.7521 3.9122 XRAY
Revenue Growth 0.1% 4.4% EXPD
Earnings Growth 15.2% 16.3% EXPD
Tradestie Score 52.3/100 58.5/100 EXPD
Profit Margin -17.1% 7.5% EXPD
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: +20.6% · 3M: +13.8% EXPD 1M: +0.6% · 3M: +13.5%

Current Technical Phase

XRAY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 58

RSI (14): 57.8 · Price: $13.37

EXPD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 44.7 · Price: $167.89

Fundamentals Snapshot

Metric XRAY EXPD
Market Cap
Forward P/E 8.6 23.6
Trailing P/E 27.5
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.5% 0.1%
Operating Margin 0.0% 0.1%
EPS -3.05 6.08
Dividend Yield 0.03% 0.01%

Frequently Asked Questions

Based on our detailed analysis, EXPD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.